Dimitri Peterlana

618 total citations
24 papers, 443 citations indexed

About

Dimitri Peterlana is a scholar working on Rheumatology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Dimitri Peterlana has authored 24 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Infectious Diseases and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Dimitri Peterlana's work include Parvovirus B19 Infection Studies (3 papers), Systemic Sclerosis and Related Diseases (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Dimitri Peterlana is often cited by papers focused on Parvovirus B19 Infection Studies (3 papers), Systemic Sclerosis and Related Diseases (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Dimitri Peterlana collaborates with scholars based in Italy and Spain. Dimitri Peterlana's co-authors include Antonio Puccetti, Claudio Lunardi, Roberto Corrocher, Elisa Tinazzi, Caterina Bason, Ruggero Beri, Sara Simeoni, Riccardo Navone, Marzia Dolcino and Nicola Tamassia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PLoS Medicine.

In The Last Decade

Dimitri Peterlana

23 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimitri Peterlana Italy 12 126 124 114 87 84 24 443
C. Deligny Martinique 15 155 1.2× 199 1.6× 207 1.8× 135 1.6× 87 1.0× 59 679
Nahide Onsun Türkiye 17 158 1.3× 112 0.9× 216 1.9× 170 2.0× 65 0.8× 95 815
Valentina Germano Italy 14 96 0.8× 261 2.1× 147 1.3× 91 1.0× 40 0.5× 18 492
F. Skowron France 16 133 1.1× 105 0.8× 88 0.8× 176 2.0× 47 0.6× 48 750
Elisabetta Borella Italy 9 100 0.8× 212 1.7× 144 1.3× 245 2.8× 26 0.3× 14 575
Roei David Mazor Israel 10 60 0.5× 163 1.3× 157 1.4× 68 0.8× 145 1.7× 23 551
Omid Zargari Iran 12 62 0.5× 63 0.5× 113 1.0× 69 0.8× 42 0.5× 39 380
Fernando Henrique Carlos de Souza Brazil 15 115 0.9× 308 2.5× 139 1.2× 493 5.7× 49 0.6× 58 695
M H Miller Australia 9 184 1.5× 160 1.3× 116 1.0× 200 2.3× 115 1.4× 12 543
M. Dandurand France 14 85 0.7× 92 0.7× 31 0.3× 173 2.0× 50 0.6× 48 664

Countries citing papers authored by Dimitri Peterlana

Since Specialization
Citations

This map shows the geographic impact of Dimitri Peterlana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Peterlana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Peterlana more than expected).

Fields of papers citing papers by Dimitri Peterlana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Peterlana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Peterlana. The network helps show where Dimitri Peterlana may publish in the future.

Co-authorship network of co-authors of Dimitri Peterlana

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Peterlana. A scholar is included among the top collaborators of Dimitri Peterlana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Peterlana. Dimitri Peterlana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterlana, Dimitri, et al.. (2025). A report of progressive multifocal leukoencephalopathy during adjuvant abemaciclib for breast cancer. Journal of NeuroVirology. 32(1). 4–4.
2.
Landolfo, Matteo, et al.. (2022). Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study. Internal and Emergency Medicine. 17(5). 1335–1341. 5 indexed citations
3.
Guarracini, Fabrizio, Massimiliano Marini, Daniele Penzo, et al.. (2021). Heart Team for Left Atrial Appendage Occlusion: A Patient-Tailored Approach. Journal of Clinical Medicine. 11(1). 176–176. 6 indexed citations
4.
Maino, Alberto, et al.. (2020). Cumulative incidence of thrombotic complications in severeCovid 19 disease. the Trento sub-intensive care unit cohort. Italian Journal of Medicine. 14. 114–114. 11 indexed citations
5.
Veccia, Antonello, et al.. (2020). Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature. Anti-Cancer Drugs. 31(5). 540–544. 8 indexed citations
6.
Torri, Emanuele, et al.. (2019). A model based on intensity of medical care may improve outcomes for internal medicine patients in Italy. PLoS ONE. 14(1). e0211548–e0211548. 10 indexed citations
7.
Peterlana, Dimitri, et al.. (2013). Stroke-like manifestations in a patient with Listeria monocytogenes abscess and Horton’s arteritis. SHILAP Revista de lepidopterología. 8(1). 64–64. 2 indexed citations
9.
Lunardi, Claudio, Marzia Dolcino, Dimitri Peterlana, et al.. (2007). Endothelial Cells' Activation and Apoptosis Induced by a Subset of Antibodies against Human Cytomegalovirus: Relevance to the Pathogenesis of Atherosclerosis. PLoS ONE. 2(5). e473–e473. 42 indexed citations
10.
Simeoni, Sara, Antonio Puccetti, Sara Moruzzi, et al.. (2006). Dermatomyositis complicated with Kaposi sarcoma: a case report. Clinical Rheumatology. 26(3). 440–442. 6 indexed citations
11.
Peterlana, Dimitri, Antonio Puccetti, Paola Caramaschi, et al.. (2006). Endothelin‐1 serum levels correlate with MCP‐1 but not with homocysteine plasma concentration in patients with systemic sclerosis. Scandinavian Journal of Rheumatology. 35(2). 133–137. 18 indexed citations
12.
Peterlana, Dimitri, Antonio Puccetti, Roberto Corrocher, & Claudio Lunardi. (2006). Serologic and molecular detection of human Parvovirus B19 infection. Clinica Chimica Acta. 372(1-2). 14–23. 31 indexed citations
13.
Navone, Riccardo, Claudio Lunardi, Roberto Gerli, et al.. (2005). Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome. Journal of Autoimmunity. 25(3). 229–234. 27 indexed citations
14.
Lunardi, Claudio, Marzia Dolcino, Dimitri Peterlana, et al.. (2005). Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array Approach. PLoS Medicine. 3(1). e2–e2. 86 indexed citations
15.
Beri, Ruggero, Dimitri Peterlana, Antonio Puccetti, et al.. (2005). [HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations].. PubMed. 96(3). 139–43. 3 indexed citations
16.
Puccetti, Antonio, Caterina Bason, Sara Simeoni, et al.. (2005). In chronic idiopathic urticaria autoantibodies against FcɛRII/CD23 induce histamine release via eosinophil activation. Clinical & Experimental Allergy. 35(12). 1599–1607. 72 indexed citations
17.
Simeoni, Sara, Elisa Tinazzi, Antonio Puccetti, et al.. (2005). Calcinosis universalis in systemic sclerosis with limited scleroderma.. PubMed. 23(1). 126–7. 1 indexed citations
18.
Simeoni, Sara, Antonio Puccetti, Dimitri Peterlana, Elisa Tinazzi, & Claudio Lunardi. (2004). Occupational allergic contact dermatitis from champignon and Polish mushroom. Contact Dermatitis. 51(3). 156–157. 5 indexed citations
19.
Peterlana, Dimitri, et al.. (2004). Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases. Clinical Rheumatology. 24(1). 18–21. 30 indexed citations
20.
Peterlana, Dimitri, Antonio Puccetti, Ruggero Beri, et al.. (2003). The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis.. PubMed. 30(9). 1907–10. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026